Myriad Genetics (MYGN) EBT Growth (3y) (2012 - 2026)
Myriad Genetics (MYGN) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.90% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 13.42% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.07% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.73% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 70.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.19% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.13% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 13.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.45% |
| Dec 31, 2025 | 44.51% |
| Sep 30, 2025 | 16.00% |
| Jun 30, 2025 | -164.33% |
| Mar 31, 2025 | -3.65% |
| Dec 31, 2024 | 3.49% |
| Sep 30, 2024 | -36.31% |
| Jun 30, 2024 | -113.92% |
| Mar 31, 2024 | 19.47% |
| Dec 31, 2023 | 29.98% |
| Sep 30, 2023 | 35.99% |
| Jun 30, 2023 | 15.08% |
| Mar 31, 2023 | 26.24% |
| Dec 31, 2022 | -65.95% |
| Sep 30, 2022 | -25.61% |
| Jun 30, 2022 | -32.47% |
| Mar 31, 2022 | -115.44% |
| Dec 31, 2021 | -141.49% |
| Sep 30, 2021 | 267.79% |
| Jun 30, 2021 | -30.28% |